SCHEMBL5019524

SCHEMBL5019524

Cc1cncnc1N[C@@H](C)c1cc2cc(F)ccc2c(CCN2CCOCC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.39
CYP3A4 P08684 7/20 0.39
LMNA P02545 6/20 0.39
CYP2D6 P10635 6/20 0.39
HIF1A Q16665 6/20 0.39
HSD17B10 Q99714 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
EGFR P00533 1/20 0.36
JAK2 O60674 2/20 0.35
JAK3 P52333 2/20 0.35
SOS1 Q07889 5/20 0.35
CYP2C19 P33261 4/20 0.35
TP53 P04637 3/20 0.35
ALOX15 P16050 3/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4569334 0.83 KDM4E (0.41) KDM4EHTTSMN1; SMN2EGFRJAK2
SCHEMBL16269981 0.69 PIK3CD (0.38) LMNASMN1; SMN2SOS1ALDH1A1
SCHEMBL4569338 0.69 PIK3CD (0.38) MEN1KMT2AKDM4EHTTSMN1; SMN2
SCHEMBL4569397 0.68 PIK3CD (0.40) CYP1A2CYP3A4LMNACYP2D6HIF1A
SCHEMBL14329217 0.68 PIK3CD (0.40) CYP1A2CYP3A4LMNACYP2D6HIF1A
SCHEMBL4569391 0.68 PIK3CD (0.42) SOS1
SCHEMBL4569416 0.68 ELANE (0.41) CYP1A2CYP3A4CYP2D6HSD17B10KDM4E
SCHEMBL4569341 0.67 PIK3CD (0.45) CYP1A2CYP3A4LMNACYP2D6HIF1A
SCHEMBL4569336 0.66 PIK3CD (0.41) LMNAKDM4EHTTEGFRALDH1A1
SCHEMBL3699149 0.66 LMNA (0.39) LMNAMEN1KMT2AKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed